PATHOLOGY REVIEW IN AN EARLY PROSTATE-CANCER DETECTION PROGRAM - RESULTS FROM THE AMERICAN-CANCER-SOCIETY NATIONAL PROSTATE-CANCER DETECTION PROJECT

被引:10
作者
MOSTOFI, FK
MURPHY, GP
METTLIN, C
SESTERHENN, IA
BATSAKIS, JG
KHALIQ, SU
NADIMPALLI, V
TAHAN, S
SIDERS, DB
KOLLIN, J
MARSH, W
OWINGS, M
SWEET, J
机构
[1] ROSWELL PK CANC INST,BUFFALO,NY 14263
[2] ARMED FORCES INST PATHOL,WASHINGTON,DC 20306
[3] PACIFIC NW CANC FDN,SEATTLE,WA
[4] UNIV TEXAS,MD ANDERSON CANC CTR,HOUSTON,TX
[5] ST JOSEPH HOSP,ST JOHN,NB,CANADA
[6] COOK CTY HOSP,CHICAGO,IL 60612
[7] NEW ENGLAND DEACONESS HOSP,BOSTON,MA 02215
[8] ST JOSEPH MERCY HOSP,CATHERINE MCAULEY HLTH SYST,ANN ARBOR,MI 48104
[9] LONG BEACH MEM MED CTR,LONG BEACH,CA
[10] OHIO STATE UNIV HOSP,COLUMBUS,OH 43210
[11] UROL CONSULTANTS,ST VINCENT MED OFF,PORTLAND,OR
[12] TORONTO GEN HOSP,TORONTO,ON,CANADA
关键词
D O I
10.1002/pros.2990270103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biopsy materials obtained in the American Cancer Society National Prostate Cancer Detection Project were reviewed at the Central Pathology Laboratory at the Armed Forces Institute of Pathology. Of 265 cases submitted, 177 were diagnosed as prostatic carcinoma, 7 as prostatic intraepithelial neoplasia (PIN), 13 as atypical glands or atypical hyperplasia, and the remaining 68 were benign hyperplasias. Irrespective of the means of detection or the grading system used (Gleason or WHO-Mostofi), a large majority of the cancers were detected as low-grade tumors. Of 27 cases of PIN reported, 20 were associated with cancer, leaving 7 cases with the sole diagnosis of PIN. These data may indicate the increased use of prostate-specific antigen (PSA), digital rectal examination (DRE), and transrectal ultrasound (TRUS) in the United States is shifting the spectrum of prostate cancer pathology toward early low-grade tumors. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 16 条
[1]  
BOSTWICK DG, 1989, UROLOGY, V36, P16
[2]  
Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171
[4]  
KASTENDIECK H, 1989, UROLOGY, V34, P28
[5]  
KOVI J, 1988, CANCER, V61, P555, DOI 10.1002/1097-0142(19880201)61:3<555::AID-CNCR2820610322>3.0.CO
[6]  
2-H
[7]   IMMUNOHISTOCHEMICAL EVIDENCE FOR IMPAIRED CELL-DIFFERENTIATION IN THE PREMALIGNANT PHASE OF PROSTATE CARCINOGENESIS [J].
MCNEAL, JE ;
ALROY, J ;
LEAV, I ;
REDWINE, EA ;
FREIHA, FS ;
STAMEY, TA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (01) :23-32
[8]   TRENDS IN PROSTATE-CANCER CARE IN THE UNITED-STATES, 1974-1990 - OBSERVATIONS FROM THE PATIENT-CARE EVALUATION STUDIES OF THE AMERICAN-COLLEGE-OF-SURGEONS-COMMISSION-ON-CANCER [J].
METTLIN, C ;
JONES, GW ;
MURPHY, GP .
CA-A CANCER JOURNAL FOR CLINICIANS, 1993, 43 (02) :83-91
[9]  
METTLIN C, 1991, CANCER, V67, P2949, DOI 10.1002/1097-0142(19910615)67:12<2949::AID-CNCR2820671202>3.0.CO
[10]  
2-X